Innovation in the API world
Innovation in the API world

CUSTOM

Working for a customer who is developing a new drug product, for a currently untreatable disease, means placing together every bit of knowledge and experience gained over the years by the company, at the disposition of the customer and service of each project, whether it is simple or complex.

 

GENERICS

Equivalent or generic drug products represent, in all countries of the world, an opportunity to ensure the presence on the market of valid therapies accessible to all.

R&D

The philosophy of the R&D Unit in PROCOS is rooted in the high technical and scientific skills by which we support Business Development in the research of new market opportunities and development of new projects

HPAPI

The HPAPI Unit has been a new and exciting challenge for PROCOS! In fact, from the very beginning, the company has moved to seek the cutting edge in the development and production of Highly Potent Active Pharmaceutical Ingredients,

Our Company

Berlin Chemie is a leading pharmaceutical company with core business sectors in Custom Synthesis and Generic API (Active Pharmaceutical Ingredient) manufacturing. Committed to ensuring sustained market growth, Berlin Chemie is dedicated to pursuing innovation without compromising its foundational identity. This commitment is demonstrated through continual investments in both the company’s infrastructure and its people, aiming to enhance and expand capabilities while fostering a dynamic and innovative work environment.

By maintaining a strong focus on both technological advancement and high-quality production standards, Berlin Chemie seeks to provide superior pharmaceutical products and services globally, ensuring it remains at the forefront of the industry.

 
 
 
 

Why Choose Us

OPERATION UNIT

Our state-of-the-art manufacturing facility is situated in Cameri, Italy. Spanning 155,000 square meters, this cutting-edge multipurpose plant is fully designed under cGMP (Current Good Manufacturing Practice) compliance. It has successfully passed rigorous audits and received approval from major regulatory authorities, including AIFA (Italian Medicines Agency), the U.S. Food and Drug Administration (FDA), and the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan.

COMMERCIAL AND ADMINISTRATIVE UNIT

While Berlin Chemie is deeply rooted locally, it is also an integral part of a global network. We maintain commercial offices in key strategic geographic areas, including Japan, the USA, and Asia, allowing us to effectively manage and expand our international presence.

R&D UNIT

At Berlin Chemie, innovation drives our operations. Our R&D unit is powered by a team of highly qualified and skilled researchers dedicated to the innovation, optimization, and rapid industrialization of processes. This focus ensures that we remain at the forefront of pharmaceutical advancements and continue to deliver high-quality, innovative solutions.

Blog & News

CPHI NORTH AMERICA 2024Hello world!

Berlin will attend CPHI North America, May 07-09 taking place at the Pennsylvania Convention Center, Philadelphia. If you are interested to meet our team and learn more about our CDMO capabilities for API and HPAPI, then please contact Alicia Xaka, Trish Luhrs and Dave Short to schedule a meeting.

Read More

CAMBIAMENTI IN CORSO

 Oggi, 6 aprile 2024, il nostro HSE Manager, Ing. Antonio Sogni ha partecipato all’evento “Cambiamenti Climatici in Corso” organizzato dal Comune di Cameri, durante il quale abbiamo avuto l’opportunità di portare il nostro impegno per la sostenibilità e la sicurezza in un contesto cruciale qual è il nostro territorio. Berlin crede fermamente nell’importanza di coniugare l’attività
+ Read More

Read More

CPhI Japan

If you are you planning to attend CPhI JAPAN 2024, join our team and fix a meeting with us to discover the latest news and business opportunities. Let’s meet in Tokyo from April 17th to 19th! We wait for you at booth 4T-03!

Read More